JEAN CADET: Open Payments
NPI 1417485491 · JOHNS CREEK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 22 payments from 8 companies in 2025. Trend: 2023 $2,552 · 2024 $1,335 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $212 |
| Neurocrine BioSciences, Inc. | 3 | $168 |
| Supernus Pharmaceuticals, Inc. | 3 | $165 |
| Alkermes, Inc. | 1 | $127 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: INGREZZA, Qelbree, SPRAVATO, LYBALVI, Auvelity, REXULTI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across GA — which companies pay providers there.
